Medicare Part D Donut Hole 2026: Phase Breakdown with Real Drug Cost Examples

The Medicare Part D donut hole 2026 refers to the coverage gap phase within Medicare Part D where beneficiaries pay a higher share of drug costs before reaching catastrophic coverage, though a new $2,000 annual out-of-pocket cap now limits total exposure. This phase has been a source of financial anxiety for beneficiaries managing prescription costs in retirement, but the rules changed significantly in 2025 with the Inflation Reduction Act's implementation. Understanding how the donut hole works is essential for anyone managing prescription costs in retirement.

How the 2025 Donut Hole Closure Changed Part D Planning

The Medicare Part D donut hole has been a source of financial anxiety for beneficiaries for years, but the rules changed significantly in 2025. Understanding how the Medicare Part D donut hole 2026 works is essential for anyone managing prescription costs in retirement.

Smart Money After 60 readers know that planning for healthcare costs in retirement requires attention to detail.¹ This single change transformed Part D planning from a mid-year cost shock into a predictable annual expense.

Before 2025, beneficiaries could enter the coverage gap phase after spending roughly $4,660 in total drug costs, then pay 25% of brand-name drug costs until reaching the catastrophic threshold of approximately $7,400 in true out-of-pocket costs (TrOOP).²

For 2026, the $2,000 out-of-pocket cap remains in place.¹ This means the coverage gap phase still exists as a structural concept within the benefit design, but beneficiaries no longer face unlimited exposure during that phase. Once a beneficiary spends $2,000 on covered Part D drugs in a calendar year, catastrophic coverage begins and they pay nothing for the remainder of the year.

The key planning shift is this: instead of worrying about when you might enter the donut hole, you now focus on how quickly you will reach the $2,000 cap. For someone taking a single brand-name medication costing $500 per month, the cap is reached in roughly four months. After that, all remaining prescriptions for the year cost nothing.

What Is the Medicare Part D Donut Hole in 2026

The Medicare Part D donut hole 2026 refers to the coverage gap phase of the Part D benefit where beneficiaries pay 25% of brand-name drug costs after meeting their deductible and initial coverage limit, but before reaching the catastrophic coverage threshold.³ While the $2,000 out-of-pocket cap eliminates the financial danger of this phase, the coverage gap still determines how much you pay before hitting that cap.

The donut hole structure in 2026 works through a standard benefit design. After you meet the annual deductible, you enter the initial coverage phase where you pay a copayment or coinsurance. Once your total drug costs reach the initial coverage limit, you enter the coverage gap phase. In this phase, you pay 25% of brand-name drug costs and 25% of generic drug costs.³ The manufacturer discount program provides a 10% discount on brand-name drugs during the gap phase for 2025-2026.⁴

The critical distinction for 2026 is that the coverage gap phase ends when your true out-of-pocket costs reach $2,000, not when you have spent a specific amount on total drug costs. This means the gap phase may be shorter or longer depending on whether you use brand-name or generic medications.

2026 Coverage Phases: Deductible, Initial Coverage, and Catastrophic

The 2026 Medicare Part D benefit has three distinct phases, each with different cost-sharing rules. The table below shows the standard benefit parameters.

The deductible phase requires you to pay the full cost of your prescriptions until you reach the deductible amount, which is approximately $590 for 2026.⁵ After meeting the deductible, you enter the initial coverage phase. During this phase, you pay either a flat copayment or 25% coinsurance, depending on your plan's specific formulary.

The initial coverage limit is approximately $2,110 for 2026.⁵ Once your total drug costs exceed this amount, you enter the coverage gap phase. In this phase, you pay 25% of both brand-name and generic drug costs. The manufacturer discount program provides a 10% discount on brand-name drugs during the gap phase, meaning the manufacturer pays 10% and your plan pays the remaining 65% of the cost.⁴

Catastrophic coverage begins once your true out-of-pocket costs reach $2,000. At this point, you pay nothing for covered Part D drugs for the remainder of the calendar year.¹

How the Donut Hole Works with Real Drug Cost Examples

Understanding the coverage gap phases requires walking through actual drug cost scenarios. Consider a beneficiary named Sarah who takes a brand-name medication for high cholesterol that costs $600 per month at retail price (illustrative example).

In January, Sarah pays the full $600 cost until she meets the $590 deductible. After that, she enters the initial coverage phase. For the next two months, she pays 25% coinsurance on her $600 monthly prescription, or $150 per month. By the end of March, her total drug costs have reached approximately $2,110, and she enters the coverage gap phase.

In the coverage gap phase, Sarah pays 25% of the brand-name drug cost, or roughly $150 per month for a typical $600 prescription. The manufacturer discount program covers 10% of the cost, and her plan covers the remaining 65%.⁴ Sarah continues paying $150 per month until her out-of-pocket costs reach $2,000. Since she already paid $590 in deductible costs and $300 in initial coverage costs, she needs to pay an additional $1,110 in the coverage gap phase.⁴ At $150 per month, this takes approximately seven months.⁴

The table below shows a comparison of brand-name versus generic drug costs in the coverage gap phase.

After the deductible and initial coverage phases, the beneficiary pays $25 per month in the coverage gap phase for a typical generic drug. Reaching the $2,000 cap would require approximately 56 months of generic drug costs, meaning the beneficiary would likely never reach catastrophic coverage in a single calendar year.

How Social Security and Retirement Withdrawals Affect Your Drug Costs

Your Social Security benefits and retirement account withdrawals directly affect your Medicare Part D costs through the income-related monthly adjustment amount (IRMAA). The Social Security Administration uses your tax return from two years prior to determine your modified adjusted gross income (MAGI), which then sets your Part D premium surcharge.⁶

For 2026, the Part D IRMAA brackets are based on your 2024 tax return. If your modified adjusted gross income exceeds certain thresholds, you pay an additional premium on top of your standard Part D plan premium. The table below shows the 2026 Part D IRMAA brackets.

For married couples filing jointly, the thresholds are approximately double the single filer amounts.⁶

A large retirement account withdrawal in a single year can push your income into a higher IRMAA bracket for two years. Suppose Michael takes a $50,000 distribution from his IRA in 2024 to fund a home renovation. This distribution increases his 2024 MAGI, which then determines his 2026 Part D IRMAA surcharge. If Michael's base MAGI is $90,000, the $50,000 distribution pushes him to $140,000, triggering a monthly Part D surcharge of $35.30 for all of 2026.⁷

IRMAA and the Donut Hole: How Higher Income Raises Your Total Bill

IRMAA surcharges increase your total Part D costs without affecting how the coverage gap phases work. The $2,000 out-of-pocket cap applies only to drug costs, not to IRMAA surcharges. This means a high-income beneficiary pays the same $2,000 maximum for drug costs but pays significantly more in total Part D expenses due to the monthly IRMAA surcharge.

Consider two beneficiaries taking the same brand-name medication. Jennifer has a MAGI of $90,000 and pays no IRMAA surcharge. Her total Part D cost for the year is $2,000 in drug costs plus her standard plan premium of approximately $400, for a total of $2,400.

Michael has a MAGI of $150,000 and pays a $35.30 monthly IRMAA surcharge. His total Part D cost for the year is $2,000 in drug costs plus $400 in standard premium plus $423.60 in IRMAA surcharges, for a total of $2,823.60.

The IRMAA surcharge is particularly painful because it is not subject to the $2,000 out-of-pocket cap. A beneficiary who reaches the catastrophic coverage threshold in March still pays the full IRMAA surcharge for all twelve months of the year.

Strategic Roth conversions can help manage IRMAA exposure. Converting a traditional IRA to a Roth IRA in a low-income year can reduce future required minimum distributions, which in turn lowers future MAGI and potential IRMAA surcharges. However, the conversion itself counts as income in the year it is done, so timing matters.

Strategies to Avoid or Minimize the Donut Hole Gap in 2026

Several strategies can help beneficiaries minimize their costs during the coverage gap phase and reach the $2,000 cap more efficiently.

First, request a formulary exception from your Part D plan. If your brand-name medication has a generic equivalent that is not on your plan's formulary, your doctor can request a formulary exception to have the generic covered at a lower tier. This reduces your cost from 25% of the brand-name price to 25% of the generic price in the coverage gap phase.

Second, use manufacturer patient assistance programs. Many pharmaceutical companies offer copay assistance cards that cover a portion of your out-of-pocket costs for brand-name medications. These programs can reduce your effective cost in the coverage gap phase from 25% to as low as 0%, depending on the program terms. However, some programs have annual limits, so timing your enrollment matters.

Third, consider the Extra Help program. The Social Security Administration offers the Extra Help program for beneficiaries with limited income and resources. This program covers most Part D costs, including premiums, deductibles, and copayments. For 2026, the income limit for Extra Help is approximately $21,870 for individuals and $29,580 for married couples.⁷

Fourth, review your Part D plan during the Annual Enrollment Period from October 15 to December 7. Plans change their formularies and cost-sharing structures each year. A plan that was optimal in 2025 may have higher copayments or a less favorable formulary in 2026. Use the Medicare Plan Finder tool to compare plans based on your specific medications.

Fifth, time your medication refills strategically. If you know you will reach the $2,000 cap in a particular month, consider filling a 90-day supply of your maintenance medications in that month. Since catastrophic coverage begins after the cap is reached, the additional medication costs $0.

Coordinating Medicare Part D with Your 401k Withdrawal Plan

Your retirement withdrawal strategy directly affects your Part D costs through the IRMAA mechanism. A well-coordinated withdrawal plan can minimize both your tax burden and your Medicare premiums.

The key principle is to manage your modified adjusted gross income to stay within your target IRMAA bracket. For a single filer, staying below approximately $106,000 in MAGI avoids any Part D IRMAA surcharge.⁶ For married couples filing jointly, the threshold is approximately $212,000.⁶

Suppose a married couple needs $80,000 per year in retirement income. They could, for example, withdraw $40,000 from a traditional IRA and $40,000 from a Roth IRA. The Roth IRA withdrawal does not count toward MAGI, so their MAGI remains at $40,000, well below the IRMAA threshold. If they instead withdrew the full $80,000 entirely from the traditional IRA, their MAGI would be $80,000, still below the threshold but with a higher tax bill.

For beneficiaries with significant traditional IRA balances, consider a multi-year Roth conversion strategy. Convert a portion of your traditional IRA to a Roth IRA each year, keeping your MAGI below the IRMAA threshold. Over several years, you can move substantial assets to a Roth IRA, reducing future required minimum distributions and their associated IRMAA impact.

The $2,000 out-of-pocket cap also affects your emergency fund planning. Since catastrophic coverage begins after $2,000 in out-of-pocket costs, you can budget for a maximum of $2,000 in annual drug costs plus your Part D premium and any IRMAA surcharges. This predictability allows for more precise retirement income planning.

Your Next Step

Review your current Part D plan's formulary and estimate your 2026 drug costs using the Medicare Plan Finder tool. Identify which of your medications are brand-name versus generic, and calculate how quickly you will reach the $2,000 out-of-pocket cap. If you take expensive brand-name medications, consider enrolling in manufacturer patient assistance programs before January 1 to reduce your costs in the coverage gap phase. For beneficiaries with high retirement account balances, schedule a consultation with a tax professional to plan Roth conversions that minimize future IRMAA surcharges.